CEO, Martin Gouldstone speaks to Vox Markets about Oncimmune and provides a commercial strategy update.

5 March 2024

In this interview, the CEO of Oncimmune Martine Gouldstone speaks to Paul Hill at Vox Markets and discusses what Oncimmune does, how it can support the pharmaceutical and biotech industry and also provides a positive update on the new commercial strategy.

Watch the whole interview below: